Sofosbuvir-based antiviral therapy provided highly treatment efficacy, safety and good tolerability for Taiwanese chronic hepatitis C patients with decompensated cirrhosis
2021 ◽
Vol Publish Ahead of Print
◽
Keyword(s):
2018 ◽
Vol 19
(1)
◽
pp. 33-36
◽
Keyword(s):
2014 ◽
Vol 29
(5)
◽
pp. 1012-1018
◽
2014 ◽
Vol 12
(1)
◽
pp. 157-158
2008 ◽
Vol 12
◽
pp. S77
Keyword(s):